The Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research funding call from the National Institutes of Health (NIH) supports the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis.

Funding Organization: National Institutes of Health (NIH), USA

Research Scope: Integration of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology

Eligibility: Applications are open to researchers at research institutions in the USA and worldwide.

Maximum Award: The award provides up to 400,000 USD per year for up to 5 years.

Application Process: Application should be submitted via the NIH ASSIST system.

Application Deadline: Letters of intent are due 5 January 2025. Applications are due on 5 February 2025.

Further information: https://grants.nih.gov/grants/guide/pa-files/PAR-25-171.html